TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

Heart surgeons alarmed by high number of young patients choosing TAVR over SAVR

Nearly 50% of patients under the age of 60 are now opting for TAVR over SAVR, according to a new study presented at STS 2024 in San Antonio. "We owe it to our patients to take a more prominent role in providing the highest quality evidence to help our patients make these major healthcare decisions," one researcher said. 

January 28, 2024
Overview of the Tootsie Roll technique for treating paravalvular leak in certain transcatheter heart valve patients. Tootsie Roll paravalvular leak transcatheter heart valves.

New ‘Tootsie Roll’ technique could help cardiologists treat PVL in transcatheter heart valves

Paravalvular leak remains a significant problem after TAVR, SAVR and even TMVR. Could a new-look interventional technique help heart teams overcome this issue and improve patient outcomes? 

January 24, 2024
Pi-Cardia ShortCut TAVR device. According to Pi-Cardia, ShortCut is the first medical device of its kind; interventional cardiologists use it to split valve leaflets in patients who have been recommended for valve-in-valve TAVR and face a heightened coronary obstruction risk.

FDA grants new valve-in-valve TAVR offering its breakthrough device designation

The new device was designed to help clinicians perform valve-in-valve TAVR on certain high-risk patients. One cardiologist familiar with the technology said it could be easily added to any preexisting TAVR workflow. 

January 23, 2024
older patient with a doctor at their house

Valve-in-valve TAVR with Medtronic’s CoreValve devices still safe and effective after 5 years

Researchers tracked five-year data from more than 200 patients, sharing their findings in the American Journal of Cardiology.

January 22, 2024
weight loss scale overweight obese lose weight pounds

TAVR in patients with severe obesity: Longer hospital stays, higher costs, more health risks

The CDC defines severe obesity, or class III obesity, as any patient with a BMI of 40 or higher. TAVR among these patients is not associated with a lower survival rate, but it does lead to many more risks.

January 19, 2024
Self-expandable TAVR cusp-overlap ICE

ICE guidance reduces risk of permanent pacemaker implantation after TAVR with a self-expandable valve

Heart teams can limit the risk of conduction disturbances that lead to permanent pacemaker implantation by utilizing both the cusp-overlap method and intracardiac echocardiography.

January 17, 2024
2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.

Valve-in-valve TAVR an effective tool for treating structural valve degeneration after SAVR

With heart teams performing valve-in-valve TAVR more and more, researchers wanted to take a fresh look at patient outcomes. Overall, they found, the procedure was linked to a low mortality rate and fewer permanent pacemakers than native-valve TAVR.

January 16, 2024
TAVR after mitral valve replacement

TAVR after mitral valve replacement linked to positive outcomes, but heart teams must plan ahead

Researchers in India performed TAVR on two relatively young patients with a preexisting mechanical mitral valve, sharing their experience in a new case report. The group highlighted the importance of planning ahead.

January 10, 2024

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup